MNKD remains a very speculative stock. The recent PR's regarding the other things in the pipeline are fairly meaningless until the financing issue is clarified. Once that is behind us perhaps we will see the pop Al was predicting.

IMO the partnership is still quite a ways from happening due to Mann's understanding of the value of the product. Should he feel good enough to extend/ re-roll the LOC and insure MannKind gets to the FDA NDA finish line we could expect to see the stock double quickly.

I rarely agree with an SA writer but this one has it right from where I sit.